Amgen Inc. (AMGN.BA)
Discovers and manufactures medicines treating cancer, autoimmune diseases, and bone disorders.
20,890.00+0.04%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+55.0%
The outlook
Amgen trades near its 52-week highs and sits above both its 50- and 200-day moving averages, indicating an uptrend in the current timeframe. Analyst sentiment leans bullish overall, though the trailing P/E ratio of 0.2 appears unusual and may warrant verification. Price movement today has been minimal.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range96% of the way from its 52-week low to high
Market cap
$2.25T
52-wk high
21,270.00
52-wk low
12,320.00
50-day avg
18,054.40
200-day avg
17,257.80
Trailing P/E
0.2